🔥🐔 BizChicken 🐔🔥

Learn About the Corporations Around You

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Hepion Pharmaceuticals, Inc.

Hepion Pharmaceuticals, Inc. logo
Market Cap: Lowest
Employees: Lowest

Rencofilstat

Hepion Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing drug therapies for chronic liver diseases, particularly through the development of Rencofilstat, a cyclophilin inhibitor aimed at treating non-alcoholic steatohepatitis (NASH) and reducing liver fibrosis and tumors.

Tags: NASH, Rencofilstat, biopharmaceutical, cyclophilin inhibitor, drug therapy, liver disease

Symbol: HEPA

Recent Price: $0.43

Industry: Biotechnology

CEO: Mr. John Patrick Brancaccio CPA

Sector: Healthcare

Employees: 22

Address: 399 Thornall Street, Edison, NJ 08837

Phone: 732 902 4000

Leadership

  • John P. Brancaccio, Interim Chief Executive Officer, Interim Chief Financial Officer, and Chairman of the Board

Last updated: 2024-12-31